Delivery Order SPE2DB24D2101-SPE2DB25FKGTF

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,935.29, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 27, 2024. The award was made on December 26, 2024, and there was no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,835.66, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract is a Firm Fixed Price Delivery Order with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,253.32, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a type of medication. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,765.42 delivery order is for OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,389.26 firm fixed price delivery order is for the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The contract has an ultimate completion date of January 8, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,081.29 Firm Fixed Price Delivery Order is for the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,169.28 firm fixed-price delivery order is for the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, with a period of performance through February 2025. The contract is not designated as a set-aside. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,759.96, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 6, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The award, valued at $1,879.98, is a Firm Fixed Price Delivery Order contract with a completion date of December 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,683.81 firm fixed-price delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKGTF
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,819.97, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period ending on February 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and there are no major subcontractors noted. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award appears to be a delivery order under that larger IDC contract vehicle.

Generated 5/7/25, 9:55 AM